Windtree Secures $520 Million to Expand BNB Treasury Strategy

  • Windtree Therapeutics has announced up to $520 million in new funding, with 99% of proceeds earmarked for BNB acquisitions, signaling one of the most aggressive crypto treasury moves by a public biotech company.